Meeting
2012 ASCO Annual Meeting
Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trial.
Authors
Michael Alexander Gordon
Keck School of Medicine of the University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, CA
Michael Alexander Gordon , Holly Gundacker , Jacqueline Benedetti , John S. Macdonald , Joaquina Celebre Baranda , Wendy J. Levin , C. D. Blanke , Wafaa Elatre , Peggy Weng , Heinz-Josef Lenz , Michael F. Press
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Gastrointestinal (Noncolorectal) Cancer
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Esophageal, Gastric, or Small Bowel
Citation
J Clin Oncol 30, 2012 (suppl; abstr 4010)
DOI
10.1200/jco.2012.30.15_suppl.4010
Abstract #
4010
Poster Bd #
2
Abstract Disclosures
Similar Posters
Poster
2017 ASCO-SITC Clinical Immuno-Oncology Symposium
HER2 gene amplification and protein overexpression in uterine clear cell carcinoma and its implications in targeted immunotherapy.
First Author: Jain Zhou
Poster
2012 Gastrointestinal Cancers Symposium
Relationship between serum HER2 level and histologic HER2 status in patients with advanced/recurrent gastric cancer.
First Author: Takahide Sasaki
Poster
2015 ASCO Annual Meeting
Defining the spectrum and "overlap" of HER2 aberrations in lung cancers: Associations of HER2 protein overexpression, HER2 amplification, and HER2 mutation.
First Author: Bob T. Li
Poster
2015 ASCO Annual Meeting
Quantitative measurement of HER2 levels by multiplexed mass spectrometry to predict survival in gastric cancer patients treated with trastuzumab.
First Author: Chan-Young Ock